XPLORE

Specialisation

Retina and Vitreous

Full title

A Phase III Double-Blind, Parallel Group, Multicenter Study to Compare the Efficacy and Safety of Xlucane versus Lucentis in Patients with Neovascular Age-Related Macular Degeneration

Promoter

Xbrane Biopharma

Start date

June 2019

Researchers

Main: Dr Anniken Burés

Co-Researchers: Dr Rafael Navarro, Dr Borja Corcóstegui, Dr Carlos Mateo, Dr Cecilia Salinas